| P50 | author | Hanns Ulrich Zeilhofer | Q42870793 |
| P2093 | author name string | Uwe Rudolph | |
| | William T Ralvenius | |
| | Dietmar Benke | |
| | Youssef Daali | |
| | Jules Desmeules | |
| | Marie Besson | |
| | Alain Matthey | |
| | Mario A Acuña | |
| P2860 | cites work | The contribution of GABAA and glycine receptors to central sensitization: disinhibition and touch-evoked allodynia in the spinal cord. | Q52215885 |
| | GABAergic modulation in central sensitization in humans | Q60684340 |
| | Hyperalgesia induced by altered glycinergic activity at the spinal cord | Q69804179 |
| | Comparative study in mice of ten 1,4-benzodiazepines and of clobazam: anticonvulsant, anxiolytic, sedative, and myorelaxant effects | Q69885733 |
| | Nociceptive responses to altered GABAergic activity at the spinal cord | Q70151834 |
| | Pharmacokinetic aspects of the interaction between clobazam and cimetidine | Q71036763 |
| | Serum and cerebrospinal fluid concentration of clobazam and N-desmethylclobazam | Q72586061 |
| | Peripheral and spinal GABAergic regulation of incisional pain in rats | Q82351823 |
| | Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metabolite | Q85073305 |
| | Complex control of GABA(A) receptor subunit mRNA expression: variation, covariation, and genetic regulation | Q27305122 |
| | Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors | Q28594296 |
| | α2-containing GABA(A) receptors: a requirement for midazolam-escalated aggression and social approach in mice | Q30368912 |
| | Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes | Q30466591 |
| | Enhancement of inhibitory neurotransmission by GABAA receptors having α2,3-subunits ameliorates behavioral deficits in a mouse model of autism | Q33837604 |
| | Neural bases for addictive properties of benzodiazepines. | Q33855956 |
| | Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. | Q33902217 |
| | A new benzodiazepine pharmacology. | Q34106026 |
| | N-desmethylclobazam: a possible alternative to clobazam in the treatment of refractory epilepsy? | Q34416248 |
| | Pharmacokinetics of N-desmethylclobazam in healthy volunteers and patients with epilepsy | Q34417380 |
| | TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates. | Q34453763 |
| | A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. | Q34554719 |
| | Evaluation of anti-hyperalgesic and analgesic effects of two benzodiazepines in human experimental pain: a randomized placebo-controlled study | Q34647740 |
| | Developing analgesics by enhancing spinal inhibition after injury: GABAA receptor subtypes as novel targets | Q35001122 |
| | Functional characterization of the 1,5-benzodiazepine clobazam and its major active metabolite N-desmethylclobazam at human GABA(A) receptors expressed in Xenopus laevis oocytes | Q35583676 |
| | HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain | Q36592958 |
| | Fast synaptic inhibition in spinal sensory processing and pain control | Q36661675 |
| | Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype | Q36793359 |
| | Antihyperalgesia by α2-GABAA receptors occurs via a genuine spinal action and does not involve supraspinal sites | Q37409646 |
| | Studying ongoing and spontaneous pain in rodents--challenges and opportunities | Q38216853 |
| | A Comparison of the α2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain. | Q39456055 |
| | Clobazam shows a different antiepileptic action profile from clonazepam and zonisamide in Ihara epileptic rats | Q44036798 |
| | Distribution of diazepam and nordiazepam between plasma and whole blood and the influence of hematocrit | Q44981311 |
| | Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice | Q46193090 |
| | Reversal of pathological pain through specific spinal GABAA receptor subtypes. | Q46803020 |
| | Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist. | Q48306835 |
| | Antihyperalgesic effect of the GABA(A) ligand clobazam in a neuropathic pain model in mice: a pharmacokinetic-pharmacodynamic study | Q48365122 |
| | Assessment of the effects of NS11394 and L-838417, α2/3 subunit-selective GABA(A) [corrected] receptor-positive allosteric modulators, in tests for pain, anxiety, memory and motor function. | Q50552915 |
| | Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms. | Q50720910 |
| | Molecular and neuronal substrate for the selective attenuation of anxiety. | Q51376038 |
| | Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. | Q51434685 |
| P304 | page(s) | 366-375 | |
| P577 | publication date | 2016-07-05 | |
| P1433 | published in | Neuropharmacology | Q15332439 |
| P1476 | title | The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesia | |
| P478 | volume | 109 | |